Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation.

Journal:
Circulation
Published:
DOI:
10.1161/circulationaha.125.075157
Affiliations:
6
Authors:
7
Go to article
Institutions Authors Share
Peking University (PKU), China
3.500000
 0.50
Karolinska Institute (KI), Sweden
1.500000
 0.21
Department of Clinical Sciences, Danderyd Hospital, Sweden
0.500000
 0.07
Kidney Research Institute (KRI), United States of America (USA)
0.500000
 0.07
Providence Inland Northwest Health Services (INHS), United States of America (USA)
0.500000
 0.07
Leiden University Medical Center (LUMC), Netherlands
0.500000
 0.07
Interested in Cardiovascular Medicine and Haematology?